Company news
Atrium Therapeutics, Inc. news in 2020
Atrium Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.
Avidity Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
December 21, 2020
Avidity Biosciences Announces Addition to the Nasdaq Biotechnology Index
December 20, 2020
Avidity Biosciences Reports Third Quarter 2020 Financial Results and Recent Highlights
November 9, 2020
Avidity Biosciences to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference 2020
November 4, 2020
Avidity Biosciences to Present at the Virtual Chardan 4th Annual Genetic Medicines Conference 2020
September 27, 2020
Avidity Biosciences to Present at Several Upcoming Virtual Scientific Meetings
September 13, 2020
Avidity Biosciences Enters into Collaboration to Study the Natural History of Myotonic Dystrophy Type 1
September 7, 2020
Avidity Biosciences to Present at the 2020 Wells Fargo Virtual Healthcare Conference
September 2, 2020
Avidity Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights
August 9, 2020
Avidity Biosciences Appoints Jae Kim, M.D. as Chief Medical Officer
July 26, 2020
Avidity Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
June 15, 2020
Avidity Biosciences Announces Pricing of Initial Public Offering
June 10, 2020